The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Arthur David J. since 2020.
This trader's CIK number is 1769331.
At the time of last reporting, Arthur David J. was the Chief Executive Officer of Salarius Pharmaceuticals, Inc.. (stock ticker symbol SLRX).
Also see all insider trading activities at Salarius Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | SLRX | 183,388 | $62,484 | 0 | $0 | 0 | $0 |
| 2021 | SLRX | 4,000 | $3,584 | 0 | $0 | 0 | $0 |
| 2020 | SLRX | 4,175 | $4,521 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-26 | SLRX | Buy | 43,900 | .18 | 7,945 |
| 2022-03-03 | SLRX | Buy | 139,488 | .39 | 54,539 |
| 2021-08-17 | SLRX | Buy | 4,000 | .90 | 3,584 |
| 2020-08-19 | SLRX | Buy | 2,000 | 1.01 | 2,020 |
| 2020-02-11 | SLRX | Buy | 2,175 | 1.15 | 2,501 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Arthur David J. (Chief Executive Officer of Salarius Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.